Your browser doesn't support javascript.
loading
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Papp, Kim; Reich, Kristian; Leonardi, Craig L; Kircik, Leon; Chimenti, Sergio; Langley, Richard G B; Hu, ChiaChi; Stevens, Randall M; Day, Robert M; Gordon, Kenneth B; Korman, Neil J; Griffiths, Christopher E M.
Affiliation
  • Papp K; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: kapapp@probitymedical.com.
  • Reich K; Dermatologikum Hamburg, Hamburg, Germany.
  • Leonardi CL; Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, Missouri.
  • Kircik L; Physicians Skin Care, PLLC, Louisville, Kentucky; Mount Sinai Medical Center, New York, New York.
  • Chimenti S; University of Rome Tor Vergata, Rome, Italy.
  • Langley RG; Dalhousie University, Halifax, Nova Scotia, Canada.
  • Hu C; Celgene Corporation, Summit, New Jersey.
  • Stevens RM; Celgene Corporation, Summit, New Jersey.
  • Day RM; Celgene Corporation, Summit, New Jersey.
  • Gordon KB; Northwestern University, Chicago, Illinois.
  • Korman NJ; University Hospitals Case Medical Center, Cleveland, Ohio.
  • Griffiths CE; Dermatology Center, Salford Royal Hospital, University of Manchester, Manchester, United Kingdom.
J Am Acad Dermatol ; 73(1): 37-49, 2015 Jul.
Article in En | MEDLINE | ID: mdl-26089047
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Thalidomide / Phosphodiesterase 4 Inhibitors Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2015 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Thalidomide / Phosphodiesterase 4 Inhibitors Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2015 Document type: Article Country of publication: United States